Skip to content

DR. MARC HAGEMAN

Active
Private limited companyfounded 1998active for 28 yearsNauwstraat 81, 9111 Sint-Niklaas, BelgiumKBO/BCE: BE 0462.602.106
Summary

DR. MARC HAGEMAN has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €195,164. Equity remains stable across the filed financial years (±0.5% per year). Its solvency ranks better than 95% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
DR. MARC HAGEMANActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€1.2mtotal assets 2025
Equity
€1.2m
Profit
€195,164
Turnover not published (micro format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 4 days early1 of 3 deeds summarised
Why 95lowers riskSector: Human health activities (NACE 86)Size: total assets €1.2mEquity €1.2m (98.5% of total assets)Figures for financial year 2025 (filed 27-07-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 57% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 98.5% of total assets
Liquidity 62+3
short-term debt 1.5% · cash 9.7%
Profitability 89-7
return on assets 16.1%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €110,000 on 30-day terms is acceptable
Liquidity ample (current ratio 59.53, compared with 15.94 in 2024, above the usual 1.5; short-term debt: 1.5% and cash: 9.7% of total assets), and 1.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 40% on liquidity, 43% on profitability and 64% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.2m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €1.2m (98.5% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 27-07-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €1.2m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
4 days early
2024
27 days late
2023
36 days early
2022
29 days late
2021
26 days early
2020
4 days late
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than triplescurrent ratio 59.53
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 5% on solvencysector median 63.0% · 20,612 companies 98.5% View
  • Positive: 7 profitable years in a rowprofit 2025: €195,164 7 years View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€1.2m
Profit
€195,164
Solvency
98.5%
Total assets▲ 14.4%
Net result
20182025
Go to Financials

Timeline

Events
33
Since
1999
Next accounts
by 31-07-2027
  1. 31-12-2024Highest result from 2018 to 2025
  2. 31-12-2024Equity above €1m
  3. 25-06-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
05-02-1998
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
4
Purpose
“De vennootschap heeft tot voorwerp de uitoefening van de geneeskunde met specialisatie…” (deed in Dutch)
Go to Articles of association

Key facts about DR. MARC HAGEMAN

What is the company number of DR. MARC HAGEMAN?
0462.602.106. In Belgium the VAT number is the company number with BE in front: BE 0462.602.106.
Where is DR. MARC HAGEMAN based?
The registered office is at Nauwstraat 81, 9111 Sint-Niklaas.Company details
What does DR. MARC HAGEMAN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. MARC HAGEMAN?
Private limited company (BV).
When was DR. MARC HAGEMAN founded?
On 05-02-1998.
Is DR. MARC HAGEMAN still active?
Yes, DR. MARC HAGEMAN is an active enterprise in the KBO register.
What is the turnover of DR. MARC HAGEMAN?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. MARC HAGEMAN profitable?
In financial year 2025, DR. MARC HAGEMAN made a profit of €195,164.
Where can I find the annual accounts of DR. MARC HAGEMAN?
DR. MARC HAGEMAN filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. MARC HAGEMAN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. MARC HAGEMAN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure